The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Adasuve

4.5 milligram(s) Powder for Inhalation

Ferrer Internacional, S.AEU/1/13/823/001

Main Information

Trade NameAdasuve
Active SubstancesLoxapine
Strength4.5 milligram(s)
Dosage FormPowder for Inhalation
Licence HolderFerrer Internacional, S.A
Licence NumberEU/1/13/823/001

Group Information

ATC CodeN05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH01 loxapine

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back